Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYK | P43405 | 3/20 | 0.47 |
| ▸ | CDK1 | P06493 | 2/20 | 0.44 |
| ▸ | CDK2 | P24941 | 2/20 | 0.44 |
| ▸ | IKBKB | O14920 | 7/20 | 0.43 |
| ▸ | CHUK | O15111 | 7/20 | 0.43 |
| ▸ | IKBKG | Q9Y6K9 | 7/20 | 0.43 |
| ▸ | JAK2 | O60674 | 5/20 | 0.42 |
| ▸ | JAK3 | P52333 | 3/20 | 0.42 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.41 |
| ▸ | PLK4 | O00444 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
| ▸ | KDR | P35968 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14063864 | 0.89 | IKBKB (0.47) | SYKCDK1CDK2IKBKBCHUK | |
| SCHEMBL14063867 | 0.87 | JAK2 (0.46) | SYKCDK1CDK2IKBKBCHUK | |
| SCHEMBL8308567 | 0.85 | IKBKB (0.50) | CDK1CDK2IKBKBCHUKIKBKG | |
| SCHEMBL14021298 | 0.85 | SYK (0.52) | SYKCDK1CDK2IKBKBCHUK | |
| SCHEMBL8308468 | 0.85 | SYK (0.47) | SYKCDK1CDK2IKBKBCHUK | |
| SCHEMBL8315467 | 0.84 | IKBKB (0.52) | IKBKBCHUKIKBKGJAK2PLK4 | |
| SCHEMBL14063869 | 0.84 | CDK1 (0.44) | CDK1CDK2IKBKBCHUKIKBKG | |
| SCHEMBL8315465 | 0.82 | HTT (0.46) | CDK1CDK2IKBKBCHUKIKBKG | |
| SCHEMBL14063895 | 0.82 | SYK (0.50) | SYKCDK1CDK2IKBKBCHUK | |
| SCHEMBL14063914 | 0.81 | SYK (0.52) | SYKCDK1CDK2IKBKBCHUK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7429599-B2 | Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK | SIGNAL PHARMACEUTICALS, LLC (US) | 2008-09-30 | — | — | US | disclosed |
| US-7429599-B2 | Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK | SIGNAL PHARMACEUTICALS, LLC (US) | 2008-09-30 | — | — | US | disclosed |